COPYRIGHT© 2018 吉林紫鑫药业股份有限公司
The company took the exclusive product of Si Miu Pill to participate in the Rheumatology Group meeting of the Rheumatology and I
From January 19th to 20th, 2018, the Association of Rheumatology and Immunology of the Chinese Medical Doctor Association organized a gout group meeting in Shenzhen. Zixin Pharmaceutical, as the only Chinese medicine pharmaceutical company, took the exclusive product of San Miao Wan.
On the morning of the 20th, the National Association of Rheumatology and Immunology of the Chinese Physicians Association attended the Gout Professional Committee (Study Group) Committee. The experts discussed the status of gout and the future professional research projects and plans for gout. Director of the Department of Rheumatology and Immunology at Guang'anmen Hospital of China Academy of Chinese Medical Sciences and chairman of the Rheumatology Subcommittee of the Chinese Society of Traditional Chinese Medicine, Jiang Quan, used a combination of Si Miao Pills and febuxostat to prevent the onset of acute gout with randomized, double-blind, and positive drugs. "Multi-center clinical study" was the theme and introduced the preliminary research plan for the treatment of gout with Si Miu Pill. Director Jiang highlighted the efficacy of Simil Pill by introducing the advantages of using four herbs from Siwei Pills in the treatment of gout treatment, selecting all herbs in production, and using basic medicine in the treatment of gout with traditional Chinese medicine. And the potential of the four-miao pill program. Afterwards, Zhu Xiaoxia, from the Department of Rheumatology and Immunology, Huashan Hospital, Fudan University, took the theme of "Si Miao Pill in the intervention of acute gouty arthritis" as the theme, expounded the progress of the preliminary study of Si Miao Pills, and the ideas and methods in the experimental process. The problems encountered, through the demonstration of experimental phenomena and experimental data, finally confirmed that Simiao Pill is effective for acute gouty arthritis, which provides the evidence basis for the study plan of Siu Miu Pill and also allows experts to Magic pill program is more confident.
This meeting enabled more gout experts to understand Zixin Pharmaceutical and Si Miao Wan, demonstrating Zixin Pharmaceutical's support for evidence-based research of Chinese patent medicine and its adherence to modernization of Chinese medicine and modern Chinese medicine concepts. By participating in the conference, Zixin Pharmaceuticals has strengthened its confidence and determination in implementing the strategy for the large variety of Siu Miu Pills to relieve the pain of more gout patients.